Clinical Trial Update: Biomarkers of Response in Blood and Tumor Tissue Samples From Patients With Unresectable Stage IV Squamous Cell Cancer of the Head and Neck Previously Treated With Cetuximab, Cisplatin, and Radiation Therapy

View source ↗

Summary

A completed clinical trial update describing biomarkers of response in blood and tumor tissue from patients with unresectable stage IV squamous cell carcinoma o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Head and Neck Cancer | Status: COMPLETED